in this issue
Chemical Week Magazine :: Newsbriefs
Companies eyeing Novartisâ€™s animal health business
6:04 AM MST | December 6, 2013
Several companies have emerged as potential buyers of Novartisâ€™s animal health business, press reports say. Novartis CEO, Joe Jimenez, said in November that the company might sell its animal health and OTC businesses if it cannot turn them into global-scale operations. Combined revenues of the two businesses were $3.7 billion in 2012, 19% down on the year before. Novartis is working on a portfolio review with Goldman Sachs, according to Bloomberg. Bayer, which earlier this year acquired Teva Pharmaceuticalâ€™s veterinary business, is one of the interested...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee